Work

Supplementary Figure 14 from Engineered SH3-Derived Sherpabodies Function as a Modular Platform for Targeted T-cell Immunotherapy

Year: 2026

Type: supplementary-materials

Abstract: Figure S14. HCC1569 breast tumor volume measurements of individual mice treated with T cells expressing constitutive or inducible Sb1205 anti-HER2 CAR (related to Figure 5B).

DOI: 10.1158/0008-5472.32707338

Authors: Rogelio A. Hernández-López, Tapio Kesti, Anna R. Mäkelä, Zhe Zhao, Wei Yu, Yurie Tonai, Hector J. Monzo, Kerttu Kalander, Sirpa Leppä, Päivi M. Ojala, Wendell A. Lim, Kalle Saksela

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W7165054080

Cites:

Cited by:

Related to: 10